Basket (0)
Wishlist (0)
Your personal newsletter
__

Drug-induced and Iatrogenic Respiratory Disease

 
Edition number: 1
Publisher: CRC Press
Date of Publication:
 
Normal price:
Publisher's listprice:
GBP 56.99
Estimated price in HUF:
27 526 HUF (26 215 HUF + 5% VAT)
Why estimated?
 
Your price:
22 021 (20 972 HUF + 5% VAT )
discount is: 20% (approx 5 505 HUF off)
Discount is valid until: 30 June 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
Add to basket
  Piece(s)

 
Short description:

Pulmonary disorders can arise as side effects to drugs which have been prescribed for other disorders, or those to which the patient has been accidentally exposed or has intentionally abused. This book will be the comprehensive definitve reference to drug-induced lung disease for the practicing respiratory physician.

Long description:
At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential reference for the practising respiratory physician.

Key features:


  • The text builds upon basics with a review of basic sciences.
  • The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease
  • A wide range of diseases are detailed from chemotherapy and radiation to biologic-induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants.
  • A range of world class contributions from key opinion leaders.

    This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians.
    • Table of Contents:

    GENERAL: Classification, diagnosis, and management of drug-induced respiratory disease. Mechanisms of chemically induced respiratory toxicities. Imaging of drug-induced lung disease. Bronchoalveolar lavage in drug-induced lung disease. Pathology of drug-induced respiratory disease. Drug allergy in lung disease. DRUG-INDUCED RESPIRATORY EMERGENCIES: Drug-induced upper airway obstruction. Drug-induced bronchospasm. Drug-induced pulmonary oedema and acute respiratory distress syndrome. Pulmonary complications of blood transfusion. Drug-induced alveolar haemorrhage. Pulmonary complications of illicit drug use. Iatrogenic tracheobronchial and chest injury. ONCOLOGY AND ALLIED CONDITIONS: Pulmonary reactions to chemotherapeutic agents: The 'chemotherapy lung'. Pulmonary reactions to novel chemotherapeutic agents and biomolecules. Radiation-induced lung disease. Pulmonary complications of bone-marrow and stem-cell transplantation. Pulmonary complications of solid-organ transplantation. Pulmonary infection induced by drugs. Therapy-induced neoplasms. NON-ONCOLOGICAL CONDITIONS: Pneumonitis induced by non-cytotoxic agents. Amiodarone pulmonary toxicity. Eosinophilic pneumonia induced by drugs. Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy. Coughing induced by drugs. Pleural disease induced by drugs. Lupus erythematosus syndrome induced by drugs. Vasculitis induced by drugs. Pulmonary hypertension induced by drugs and toxins. Respiratory involvement from herbals.